CrushSCI.com
68.9平均天数
55中位天数
12最短天数
238最长天数
1,1372025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

71 天

Real-World Assessment of Prophylactic Anakinra on Neurotoxicity and Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed and Refractory B-Cell Lymphoma: An Inverse Probability of Treatment Weighting Analysis

作者
Neela Easton; Mia Andreoli; Herman van Besien; Caitlin Gribbin; Michelle Pasciolla; Anna Alperovich; Mateo Mejia Saldarriaga; Barbara Ma; Nora Chokr; Amer Assal; Joshua Fein; Sebastian Mayer; Alexandra Gomez Arteaga; Daniel Choi; Tsiporah Shore; Christopher S. Hackett; Juliet Barker; Samuel Yamshon展开收起
作者单位
NewYork-Presbyterian/Weill Cornell, Hematology & Medical Oncology, New York, New York; NewYork-Presbyterian/Weill Cornell Medical Center, Medicine, New York, New York; Perlmutter Cancer Center, NYU Langone, New York, New York展开收起
PDF源文件 DOI 网页
12 天

T-Cell Lymphoma Associated With CAR-T Cell Therapy: A Bayesian Disproportionality Analysis of a National Database

作者
Connor Frey展开收起
作者单位
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada展开收起
PDF源文件 DOI 网页
79 天

Comparative Evaluation of Single-Dose and Split-Dose Melphalan Conditioning Concerning Toxicity Profiles and Engraftment Kinetics: A Propensity Score-Matched Analysis

作者
Ceren Uzunoğlu Güren; Derya Demirtaş; Ezel Elgün; Tuğçe Bulun; Elif Suyanı; Bilal Aygün; Didar Yanardağ Açık; Fahir Özkalemkaş; Vildan Özkocaman; Asu Fergün Yılmaz; Ayşe Tülin Tuğlular; Işık Atagündüz; Tayfur Toptaş展开收起
作者单位
Department of Hematology, Marmara University Hospital, Istanbul, Turkey; Department of Hematology, Adana City Training and Research Hospital, Adana, Turkey; Department of Hematology, Bursa Uludağ University, Bursa, Turkey; Department of Hematology, Acibadem Fulya Hospital, Istanbul, Turkey展开收起
PDF源文件 DOI 网页
48 天

Outcomes and Safety of CAR-T Cell Therapy in B-NHL Patients With Reduced Left Ventricular Ejection Fraction

作者
Alexandra E. Rojek; Jia Guo; Justin Kline; Satyajit Kosuri; Michael R. Bishop; Jeanne DeCara; Peter A. Riedell展开收起
作者单位
David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, Illinois; Section of Cardiology, Department of Medicine, University of Chicago, Chicago, Illinois展开收起
PDF源文件 DOI 网页
75 天

Impact of ASTCT Toxicity Grading System on Outcomes After CAR-T for Mature B-Cell Malignancies

作者
Marina Gomez-Llobell; Silvia Escribano Serrat; Maria Bromberg; Venkatraman Seshan; Sean Devlin; Sigrun Einarsdottir; Ori Ben Valid; Noa Golan-Aceb; Ronit Marcus; Avichai Simoni; Ofrat Beyar-Katz; Shoshan Perek; Ali Abed Al Wahad; Magdalena Corona; Kai Rejeski; Sandeep S. Raj; Parastoo Dahi; Michael Scordo; Gunjan L. Shah; M. Lia Palomba; Gilles Salles; Jae H. Park; Roni Shouval; Abraham Avigdor; Jaime Sanz; Miguel-Angel Perales展开收起
作者单位
Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Complutense University of Madrid, Madrid, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York; Department of Medicine, Weill Cornell Medical College, New York, New York; Hematology and Bone Marrow Transplantation, Sheba Medical Center, Ramat Gan, Israel; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel; Institute of Hematology, Lady Davis Carmel Medical Center, Haifa, Israel; Department of Medicine III – Hematology/Oncology, LMU University Hospital, LMU Munich, Munich, Germany; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Hematology Department, Hospital Universitari i Politècnic La Fe, Departament de Medicina Universitat de Valencia, CIBERONC, Instituto Carlos III, Spain展开收起
PDF源文件 DOI 网页
55 天

Vaccine-Induced Anti-HBs Response is Associated with Protection Against Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Randomized Trial

作者
Masahiro Onozawa; Shigeru Kusumoto; Yachiyo Kuwatsuka; Takayoshi Miyazono; Masatsugu Tanaka; Yuho Najima; Kohei Okada; Souichi Shiratori; Takayuki Sato; Junya Kanda; Yuichiro Inagaki; Tohru Murayama; Kaoru Hatano; Koichi Onodera; Masatoshi Sakurai; Shinya Endo; Takahiro Kumode; Hidehiro Itonaga; Yukiyoshi Moriuchi; Nobuhiro Kanemura; Tatsuya Imi; Taro Edahiro; Nobuaki Fukushima; Masahiro Oura; Shunsuke Yui; Mitsumasa Watanabe; Tomomi Toubai; Toshihiko Ando; Daisuke Nakamura; Masaharu Tamaki; Yasutaka Kakinoki; Takahiro Okada; Nobuaki Nakano; Takayoshi Tachibana; Hiroaki Shimizu; Shuichi Ota; Shinsuke Iida; Masaya Sugiyama; Yoshiko Atsuta; Takanori Teshima; Tomoharu Yoshizumi; Masashi Mizokami展开收起
作者单位
Department of Hematology, Hokkaido University Hospital, Sapporo, Japan; Department of Hematology and Cell therapy, Aichi Cancer Center, Nagoya, Japan; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan; Department of Hematology, Imamura General Hospital, Kagoshima, Japan; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan; Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan; Department of Hematology, Graduate School of Medicine, Kyoto University Hospital, Kyoto, Japan; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan; Department of Hematology, Hyogo Cancer Center, Akashi, Japan; Department of Medicine, Division of Hematology, Jichi Medical University, Shimotsuke, Japan; Department of Hematology, Tohoku University Hospital, Sendai, Japan; Department of Medicine, Division of Hematology, Keio University School of Medicine, Tokyo, Japan; Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan; Hematology and Rheumatology, Kindai University, Osaka, Japan; Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan; Department of Hematology, Sasebo City General Hospital, Sasebo, Japan; Department of Hematology & Infectious Disease, Gifu University Hospital Gifu, Japan; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan; Department of Hematology and Oncology, Konan Kosei Hospital, Konan, Japan; Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan; Department of Hematology, Nippon Medical School, Tokyo, Japan; Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan; Department of Hematology and Cell Therapy, Yamagata University Hospital, Yamagata, Japan; Department of Internal Medicine, Division of Hematology, Respiratory Medicine and Oncology, Faculty of Medicine, Saga University, Saga, Japan; Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan; Department of Hematology, Shimane University Hospital, Izumo, Japan; Department of Viral Pathogenesis and Controls, National Institute of Global Health and Medicine, Japan Institute for Health Security, Kohnodai, Japan; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Genome Medical Sciences Project, National Institute of Global Health and Medicine, Japan Institute for Health Security, Konodai, Japan; Molecular and Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan展开收起
PDF源文件 DOI 网页

FAQ

Transplantation and Cellular Therapy审稿要多久?

截至2026-11-13,CrushSCI 收录了 Transplantation and Cellular Therapy 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 12 天(T-Cell Lymphoma Associated With CAR-T Cell Therapy: A Bayesian Disproportionality Analysis of a National Database,2026-05-28 收稿,2026-06-09 录用),最慢一篇用了 238 天;平均 68.9 天,中位数 55 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。